ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+17.74%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$163M
AUM Growth
-$62.3M
(-28%)
Cap. Flow
-$54.6M
Cap. Flow
% of AUM
-33.61%
Top 10 Holdings %
Top 10 Hldgs %
62.79%
Holding
54
New
8
Increased
9
Reduced
9
Closed
20
Top Buys
| 1 |
Terns Pharmaceuticals
TERN
|
$7.63M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$6.36M |
| 3 |
Mersana Therapeutics
MRSN
|
$5.57M |
| 4 |
Rocket Pharmaceuticals
RCKT
|
$5.09M |
| 5 |
Keros Therapeutics
KROS
|
$3.84M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$17.4M |
| 2 |
Relmada Therapeutics
RLMD
|
$13.5M |
| 3 |
Xenon Pharmaceuticals
XENE
|
$9.84M |
| 4 |
BLSA
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
|
$8.45M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$7.32M |
Sector Composition
| 1 | Healthcare | 99.99% |
| 2 | Financials | 0% |